GENEVA, June 2 -- JUVENTAS CELL THERAPY LTD. (Building 5, No. 8, Haitai Development 3rd Road, Huayuan Industrial Zone, Binhai High-tech ZoneBinhai New Area, Tianjin 300384), 合源生物科技(天津)有限公司 (中国天津市滨海新区滨海高新区华苑产业园(环外)海泰发展三道8号5号楼) filed a patent application (PCT/CN2024/133151) for "CD7-TARGETING HUMANIZED ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, AND USE THEREOF" on Nov 20, 2024. With publication no. WO/2025/108294, the details relate...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.